The Life Sciences in New York Statetag:typepad.com,2003:weblog-1043382008-02-11T19:49:04-05:00A blog about the life sciences industry in New York and around the world, with commentary on venture capital and entrepreneurship, financial markets, and anything else that happens to strike me as interesting...by Carlos N. Velez, Ph.D. TypePadThis is an XML content feed. It is intended to be viewed in a newsreader or syndicated to another site.Biotechnology Business Development - Book Available Nowtag:typepad.com,2003:post-454751382008-02-11T19:49:04-05:002008-02-11T19:49:04-05:00I'm honored to have made a small contribution to this excellent collection of articles and essays on biotech business development. Do check it out and let me know if it is helpful. Best Practices in Biotechnology Business Development Experts from...Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2008/02/biotechnology-b.htmlBioSpecifics Financingtag:typepad.com,2003:post-442427682008-01-16T13:42:16-05:002008-01-16T13:42:16-05:00More news from New York, this time from Long Island. BioSpecifics received fresh cash of $2+ million. BioSpecifics is an interesting company, and their history is summarized here. Basically, they developed a topical collagenase product, which was then sold. The...Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2008/01/biospecifics-fi.htmlProgenics Initiates Phase II in HIVtag:typepad.com,2003:post-442404482008-01-16T12:50:33-05:002008-01-16T12:50:33-05:00Tarrytown-based Progenics Pharmaceuticals announced that it is entering Phase II for PRO 140, an antibody that blocks HIV viral entry by blocking the CCR5 receptor. What I find interesting is that they are looking to study this antibody in patients...Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2008/01/progenics-initi.htmlWine…in pill formtag:typepad.com,2003:post-438545822008-01-08T14:30:36-05:002008-01-08T14:30:36-05:00I'm all for drug development in diabetes. But I still prefer taking my resveratrol by the glass, preferably in the form of a pinot noir… Some day, if all goes well in the lab, you may be able to take...Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2008/01/winein-pill-for.htmlDismal, indeedtag:typepad.com,2003:post-438002582008-01-07T15:11:18-05:002008-01-07T15:11:18-05:00Once again, FDA approvals are down. This is old news, of course. The question really is, why? And what can we do about it? "FDA's official tally will probably be 18, including two therapeutic biologics approved by the Center for...Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2008/01/dismal-indeed.htmlMarketing $ >> R&D $tag:typepad.com,2003:post-436769682008-01-04T13:22:11-05:002008-01-04T13:22:11-05:00Drug industry spends nearly twice as much on marketing than on research and development I'm shocked…shocked to learn that this is a marketing-driven industry! "In their analysis of data from two market research companies, IMS and CAM, Marc-André Gagnon and...Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2008/01/marketing-rd.htmlF.D.A. Is Unable to Ensure Drugs Are Safetag:typepad.com,2003:post-410276362007-11-02T13:52:17-04:002007-11-02T13:52:17-04:00This is rather frightening, no? The Food and Drug Administration cannot guarantee the safety of the nation’s drug supply because it inspects few foreign drug manufacturers and the inspections it does carry out abroad are less rigorous than those performed...Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2007/11/fda-is-unable-t.htmlEmisphere Technologies, Inc. Moves Into New Corporate Headquarterstag:typepad.com,2003:post-409150622007-10-31T10:02:53-04:002007-10-31T10:02:53-04:00OK, but I’m still calling them a Tarrytown-based company. Emisphere Technologies, Inc. today announced it will move its corporate headquarters from Tarrytown, New York to Cedar Knolls, New Jersey Emisphere Technologies, Inc. Moves Into New Corporate Headquarters.Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2007/10/emisphere-techn.htmlOSI Pharmaceuticals Rises on 3Q Results: Financial News - Yahoo! Financetag:typepad.com,2003:post-407301102007-10-26T14:51:22-04:002007-10-26T14:51:22-04:00NEW YORK (AP) -- Shares of OSI Pharmaceuticals Inc. rose Friday after it raised its 2007 guidance on better-than-expected third-quarter results, and analysts predicted renewed growth for the biotechnology company's flagship drug. OSI Pharmaceuticals Rises on 3Q Results: Financial News...Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2007/10/osi-pharmaceuti.htmlInhaled insulin: make or break?tag:typepad.com,2003:post-405999702007-10-23T16:58:10-04:002007-10-23T16:58:10-04:00Fair question. I don’t blame Lilly for taking the stance that they are taking. In fact, I don’t think Lilly has much of a choice at this point. It’s interesting that Novo is already lowering expectations with their product by...Carlos N Velezhttp://nylifesci.typepad.com/life_sciences_in_ny/2007/10/inhaled-insulin.html